Transform the patient's world
Transparency
We believe that transparency is key to building and maintaining confidence and trust in us, and in our medicines. Our relationship with healthcare professionals (HCPs) and healthcare organisations (HCOs) plays a vital role in the development and delivery of medicines. We want to ensure that patients and others have confidence that these relationships are open and transparent.
Our transfers of value to individual healthcare professionals and healthcare organisations from 2015, have been submitted to the ABPI disclosure database and IPHA disclosure website.
Patient Organisation Disclosure
Disclosure 2025
|
Year |
Recipient name / category |
Amount |
Purpose |
|
2025 |
Eczema Outreach Support (EOS) |
£15,000 |
Grant provided to EOS, in the form of financial support of their project 'Helping Children and Young People with Eczema to Thrive'. |
|
2025 |
National Eczema Society |
£24,000 |
Donation provided to National Eczema Society, in the form of sponsorship funding. |
|
2025 |
Psoriasis Association |
£3,500 |
Meeting Sponsorship, in the form of a financial contribution towards 'Psoriasis Association Annual Conference 2025 – Right Treatment: Right Time'. |
Disclosure 2024
|
Year |
Recipient name / category |
Amount |
Purpose |
|
2024 |
Eczema Outreach Support (EOS) |
£15,000 |
Grant to Patient Organisation for addressing the unmet needs of neurodiverse children with eczema in the UK |
|
2024 |
Eczema Outreach Support (EOS) |
£250 |
Consultancy payment made to patient engaged via Patient Organisation. |
|
2024 |
Psoriasis Association |
£2,500 |
Sponsorship in the form of a financial contribution towards the Psoriasis Association Annual Conference 2024. |
|
2024 |
Allergy UK |
£384.62 |
Consultancy payment made to patient engaged via Patient Organisation. |
Disclosure 2023
|
Year |
Recipient name / category |
Amount |
Purpose |
|
2023 |
National Eczema Society |
£4,620 |
Support for the eczema awareness patient campaign |
|
2023 |
National Eczema Society |
£10,000 |
Charitable donation (Employee nomination following You Fit challenge) |
|
2023 |
Members of public (aggregate) |
£500 |
Fees for services |
Code of Ethics
Almirall is committed to operate ethically and in compliance with the laws and regulations applicable to the industry. Our conduct is guided by respect for these applicable laws and regulations, fairness, integrity, and transparency. Everyone who works for Almirall, either as an employee or through a business partnership, must comply with the standards contained in the Code of Ethics.
Almirall employees are regularly trained on the Code of Ethics.
What will you find in the document?
- Almirall’s Commitment: Our Responsibilities
- Our Team: Respecting Each Other
- Our Company: Protecting Company Assets
- Our Stakeholders: Playing by the Rules
- Serving the Community and Society: Our Social and Environmental Commitment
Anti-Bribery and Anti-Corruption Policy
At Almirall, we are fully committed to conducting business in an ethical and honest manner, implementing and enforcing systems to ensure the prevention of bribery and corruption. This Anti-Bribery and Anti-Corruption Policy responds to the need to confirm the aforementioned commitment and establishes the common principles to which the company has voluntarily adhered regarding Anti-Bribery and Anti-Corruption rules, as well as the corresponding standard common practices.
To make sure this mandatory Anti-Bribery and Anti-Corruption Policy (ABAC) policy is understood by all Almirall employees, the Almirall Business Integrity Guide (ABIG) was launched in 2022, followed by the related training course.
SpeakUp! Channel
At Almirall, we believe acting with integrity is everyone’s responsibility. We encourage anyone to report concerns about conduct believed to be unethical or illegal. The confidential SpeakUp! channel is available to employees and external stakeholders to report potential breaches of law, our Code of Ethics, guidelines, or company policies. This channel is not for reporting adverse events or side effects. Information on how to report product safety concerns through the appropriate pharmacovigilance channels can be found in the quick links in the footer of this page.
You can access SpeakUp! from any web browser, mobile phone, tablet, or similar by using the following link:
https://almirall.integrityline.com/
The system is available 24 hours a day, 7 days a week. If you prefer to share your concern via the automated telephone system, please use one of the numbers below. You will need to reference the following company code when prompted.
Company Code : 9108
- France: +33 1 872 122 91
- Germany: +49 309 925 71 46
- Italy: +39 0281 480 081
- Poland: +48 221 523 361
- Portugal: +351 304 502 651
- Spain: +34 910 477 636
- UK: +44 203 885 00 64
- US: +1-213-279-1015